William Winsley

"NABP thanks the North Dakota, Ohio, and Virginia PMPs for being on the forefront of PMP Interconnect with their signing of memorandums of understanding," says NABP Chairperson William T. Winsley, MS, RPh.. "Participation of PMPs nationwide is a key component of successfully fighting the diversion and abuse of controlled substances. Creating a web of connected PMPs will enhance the benefits of these programs by providing the means for physicians and pharmacists to more easily identify patients with prescription drug problems, especially if that patient is crossing state lines to obtain those drugs." Winsley is also Executive Director of the Ohio State Board of Pharmacy. Now here's where things get interesting -- very interesting. The NABP Foundation has received a $1 million grant from Purdue Pharma L.P. to support the deployment of the PMP Interconnect.

NABP has contracted Appriss, Inc, to develop and host PMP Interconnect, and the Association convened a meeting on January 5-6, 2011, with PMP administrators to discuss details as to how the "secure" system will work.

Let me see if I follow this $1,000,000 money trail.  Mr. Winsley takes the check from Purdue Pharma, the same company who lied about the dangers of OxyContin and unleashed death and addiction in the State of Ohio and throughout the U.S. in unprecedented destruction of human life. Mr. Winsley's NABP contracted Appriss, Inc, to develop and host this PMP Interconnect. Appriss, Inc. is a "corporate member" of the National Association of Drug Diversion Investigators (NADDI) - funded by Purdue Pharma. Want to bet that NADDI tracks the prescription drug problem in Ohio as a partner with Appriss? Want to bet that with "input" from Purdue Pharma as part of this fraternity of corporate members that the figures will be less than honest?  Think you have some explaining to do to Governor Kasich - Mr. Winsley? I sure think you do.

Then there is Danna Droz, R.Ph., J.D., Program Administrator of the Prescription Drug Monitoring Program of the Ohio State Pharmacy Board. In 2001, Ms. Droz served on a 14-member advisory board assembled by Purdue Pharma for the Kentucky Cabinet of Health Services. Kentucky was seeking solutions in dealing with the OxyContin problems in their state. Ms. Droz was among other current and former public officials working in some capacity with Purdue Pharma in Kentucky. Since Droz was serving on a national advisory board funded by the manufacturer of the pain reliever OxyContin, an Executive Ethics Commission inquiry on Droz having a conflict of interest with Purdue Pharma was initiated.